BevacizumabDeath due to treatment related adverse event: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-017-24394-2
中图分类号
学科分类号
摘要
引用
收藏
页码:123 / 123
相关论文
共 50 条
  • [22] Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report
    Shen, Chia -, I
    Yeh, Yi-Chen
    Chiu, Chao-Hua
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (05):
  • [23] Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report
    Tanaka, Takaaki
    Asakura, Shoji
    Hisamatsu, Kazuya
    Fujimoto, Nobukazu
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (07):
  • [26] Adverse event due to a likely interaction between sodium aescinate and ginkgo biloba extract: a case report
    Ji, H.
    Zhang, G.
    Yue, F.
    Zhou, X.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (02) : 237 - 238
  • [27] Susac’s syndrome as an immune-related adverse event after pembrolizumab: a case report
    M. De Groot
    A. Compter
    A. J. De Langen
    D. Brandsma
    Journal of Neurology, 2020, 267 : 282 - 284
  • [28] Susac's syndrome as an immune-related adverse event after pembrolizumab: a case report
    De Groot, M.
    Compter, A.
    De Langen, A. J.
    Brandsma, D.
    JOURNAL OF NEUROLOGY, 2020, 267 (01) : 282 - 284
  • [29] A Unique Adverse Event of Radiotherapy in a Patient With IgG4-related Disease: A Case Report
    Aimi, Hisao
    Murai, Taro
    Takino, Kazuki
    Naito, Wataru
    Miura, Ichiro
    Hata, Masaharu
    Inoue, Tomio
    Omura, Motoko
    IN VIVO, 2023, 37 (06): : 2840 - 2844